Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.

Sarma AV, Dunn RL, Lange LA, Ray A, Wang Y, Lange EM, Cooney KA. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study. Prostate. 2008 Feb 15; 68(3):296-305.

View in: PubMed

subject areas

3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Aged
Case-Control Studies
Cytochrome P-450 Enzyme System
DNA, Neoplasm
Haplotypes
Humans
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor I
Isoenzymes
Male
Michigan
Middle Aged
Polymerase Chain Reaction
Polymorphism, Single Nucleotide
Prostatic Neoplasms

authors with profiles

Ethan Lange
Leslie Lange

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium